share_log

Biodexa Pharmaceuticals | EFFECT: Others

SEC announcement ·  May 3 18:06
Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007806 and File Number 333-240984, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing Biodexa Pharmaceuticals to proceed with the actions outlined in the amendment.
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007806 and File Number 333-240984, was a post-effective amendment (POS AM) to a previously filed registration statement. This notice of effectiveness indicates that the SEC has reviewed and accepted the company's submission, allowing Biodexa Pharmaceuticals to proceed with the actions outlined in the amendment.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.